Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Postpartum Depression Market from 2024 to 2025?

The market size for postpartum depression has seen a significant expansion in recent times. The growth from $12.15 billion in 2024 to $16.09 billion in 2025, represents a compound annual growth rate (CAGR) of 32.4%. Increased awareness of maternal mental health, advancements in research, public health efforts, and increased screenings have all contributed to the upward trend observed during the historic period.

What Is the Projected Market Size of the Postpartum Depression Market?

In the upcoming years, the market size for postpartum depression is projected to undergo massive expansion, with the expectation of reaching a value of $49.4 billion in 2029, representing a compound annual growth rate (CAGR) of 32.4%. Factors contributing to the forecasted growth include the rise in telehealth services, advancements in pharmacology, maternal mental health laws, and the expansion of the mental health workforce. Major trends expected during this period encompass integrated care models, peer support programs, perinatal mental health apps, and mental health screening tools.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Who are the Major Competitors in the Postpartum Depression Market Outlook?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

What Is Fueling Growth in the Postpartum Depression Market?

The proliferation of postpartum depression cases is anticipated to fuel the expansion of the postpartum depression market. Postpartum depression, an intensified worry developed after childbirth, often presents physical symptoms. The condition often goes hand in hand with postnatal depression and postpartum anxiety, with symptoms potentially surfacing within a year of birth. Frequent treatment methods include psychotherapy, otherwise known as talk therapy or mental health counselling, medication, or a combination of both, all of which contribute to market growth. For instance, a February 2022 survey of 1.1 million moms conducted by the University of Virginia School of Medicine (UVA SoM) revealed the highest risk of postpartum depression among first-time mothers, mothers under 25 and mothers of twins. Data showed 10% of women aged 18-24 reported symptoms, while 11.3% of twin mothers and 8.3% of single-child mothers reported symptoms. Therefore, the growing prevalence of postpartum depression cases is set to boost the postpartum depression market.

Rising Childbirth Rates: A Key Influencer in the Postpartum Depression Market Growth

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Which Postpartum Depression Market Segments Are Growing the Fastest?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Which Industry Trends Are Shaping the Future of the Postpartum Depression Market?

Firms in the postpartum depression market are focusing on innovative products to maintain their market standing. There is a growing demand for innovation due to limited options for treatment, driving the need for more instant-acting therapies and inventive care for postpartum depression. For example, in February 2023, Biogen Inc., and Sage Therapeutics Inc., both US-based firms in biotechnology and biopharmaceuticals respectively, reported the approval by the United States Food and Drug Administration (FDA) of an NDA (new drug application) for zuranolone, for managing major depressive disorder (MDD) and postpartum depression (PPD). The drug under testing, zuranolone, is a potential medication designed as a 14-day, once-daily, swift-acting oral therapy for people with MDD and PPD. Zuranolone, a type of neuroactive steroid, works as a positive allosteric modulator of GABA-A receptors, presenting a unique mode of action. It aims to help those suffering from depression by quickly resetting imbalanced neural networks to aid in restoring brain functionality. It manipulates brain networks that regulate mood, alertness, behavior, and even cognition.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Countries Are Leading the Postpartum Depression Market?

North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13024

This Report Delivers Insight On:

1. How big is the postpartum depression market, and how is it changing globally?

2. Who are the major companies in the postpartum depression market, and how are they performing?

3. What are the key opportunities and risks in the postpartum depression market right now?

4. Which products or customer segments are growing the most in the postpartum depression market?

5. What factors are helping or slowing down the growth of the postpartum depression market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model